Methodological Issues in Taquet et al.‘s analysis preclude any conclusions regarding AS01 adjuvant’s specific role in dementia prevention
Crossref DOI link: https://doi.org/10.1038/s41541-025-01309-4
Published Online: 2025-12-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Williams, S. Elizabeth
Luisi, Kate
Liang, Caihua
Cane, Alejandro
Begier, Elizabeth
Text and Data Mining valid from 2025-12-05
Version of Record valid from 2025-12-05
Article History
Received: 29 July 2025
Accepted: 4 November 2025
First Online: 5 December 2025
Competing interests
: All authors are employed by Pfizer, Inc.